| Serial Number | 88193779 |
| Word Mark | ABIDE |
| Filing Date | Wednesday, November 14, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, August 1, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 30, 2019 |
| Goods and Services | Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating diseases involving lipid signaling pathways; research and development in pharmacology for the purpose of treating diseases involving the signaling pathways of the central nervous system; medical research for use in treating central nervous system disorders; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases; pharmaceutical research in the fields of immunology, namely, rheumatology, oncology, namely, immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology, namely, fertility, infectiology, namely, virology, ophthalmology, hepatology, neurology, geriatrics, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and pharmaceutical research tool development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in drug development; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for improving pharmacological properties; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in connection with a wide variety of therapeutic areas |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 11, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | H. LUNDBECK A/S |
| Party Type | 22 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Valby DK2500 DK |
| Party Name | LUNDBECK LA JOLLA RESEARCH CENTER, INC. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | DEERFIELD, IL 60015 |
| Party Name | Abide Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Abide Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Monday, August 1, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, August 1, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Saturday, December 4, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 3, 2021 | SOU EXTENSION 5 GRANTED |
| Tuesday, November 23, 2021 | SOU EXTENSION 5 FILED |
| Friday, December 3, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, November 23, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 16, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, November 16, 2021 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, November 16, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, November 16, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, May 28, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 26, 2021 | SOU EXTENSION 4 GRANTED |
| Wednesday, May 26, 2021 | SOU EXTENSION 4 FILED |
| Wednesday, May 26, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 8, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 4, 2020 | SOU EXTENSION 3 GRANTED |
| Friday, December 4, 2020 | SOU EXTENSION 3 FILED |
| Friday, December 4, 2020 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 11, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 9, 2020 | SOU EXTENSION 2 GRANTED |
| Tuesday, June 9, 2020 | SOU EXTENSION 2 FILED |
| Tuesday, June 9, 2020 | SOU TEAS EXTENSION RECEIVED |
| Monday, June 8, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, June 8, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, June 8, 2020 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Monday, June 8, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 8, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, June 8, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, April 29, 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, December 19, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 17, 2019 | SOU EXTENSION 1 GRANTED |
| Tuesday, December 17, 2019 | SOU EXTENSION 1 FILED |
| Tuesday, December 17, 2019 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 9, 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, June 25, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 30, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 30, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 10, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, March 22, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, March 22, 2019 | ASSIGNED TO LIE |
| Wednesday, February 27, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 27, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, February 27, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 27, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 27, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, February 19, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, December 11, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 17, 2018 | NEW APPLICATION ENTERED |